The DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.
Targeting protein aggregation for the treatment of degenerative diseases
Open accessAbstract
The aggregation of specific proteins is hypothesized to underlie several degenerative diseases, which are collectively known as amyloid disorders. However, the mechanistic connection between the process of protein aggregation and tissue degeneration is not yet fully understood. Here, we review current and emerging strategies to ameliorate aggregation-associated degenerative disorders, with a focus on disease-modifying strategies that prevent the formation of and/or eliminate protein aggregates. Persuasive pharmacological and genetic evidence now supports protein aggregation as the cause of postmitotic tissue dysfunction or loss. However, a more detailed understanding of the factors that trigger and sustain aggregate formation and of the structure–activity relationships underlying proteotoxicity is needed to develop future disease-modifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–292 of 292
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses
Connelly, S., Choi, S., Johnson, S. M., Kelly, J. W., & Wilson, I. A. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.12.009 · Cited by 176
Self-citationDistinct synthetic Aβ prion strains producing different amyloid deposits in bigenic mice
Stöhr, J., Condello, C., Watts, J. C., Bloch, L., Oehler, A., Nick, M., DeArmond, S. J., Giles, K., DeGrado, W. F., & Prusiner, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408968111 · Cited by 176
Lashuel, H. A., Wurth, C., Woo, L., & Kelly, J. W. (1999) · Biochemistry · doi:10.1021/bi991021c · Cited by 176
Self-citationNerve inflammation halts trial for Alzheimer's drug
Check, E. (2002) · Nature · doi:10.1038/415462a · Cited by 176
Lee, J. P., Stimson, E. R., Ghilardi, J. R., Mantyh, P. W., Lu, Y.-A., Felix, A. M., Llanos, W., Behbin, A., Cummings, M., Van Criekinge, M., et al. (1995) · Biochemistry · doi:10.1021/bi00015a033 · Cited by 170
Irwin, D. J., Abrams, J. Y., Schonberger, L. B., Leschek, E. W., Mills, J. L., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.1933 · Cited by 168
Tau Mutations in Neurodegenerative Diseases
Wolfe, M. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800013200 · Cited by 168
Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones
Udan-Johns, M., Bengoechea, R., Bell, S., Shao, J., Diamond, M. I., True, H. L., Weihl, C. C., & Baloh, R. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt408 · Cited by 165
Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy
Yamashita, T., Ando, Y., Okamoto, S., Misumi, Y., Hirahara, T., Ueda, M., Obayashi, K., Nakamura, M., Jono, H., Shono, M., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318248df18 · Cited by 163
Olofsson, B., Backman, C., Karp, K. H., & Suhr, O. B. (2002) · Transplantation · doi:10.1097/00007890-200203150-00015 · Cited by 157
Tojo, K., Sekijima, Y., Kelly, J. W., & Ikeda, S. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.08.014 · Cited by 153
Self-citationPeripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
Clavaguera, F., Hench, J., Lavenir, I., Schweighauser, G., Frank, S., Goedert, M., & Tolnay, M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1231-5 · Cited by 153
Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease
Ferretti, M. T., Bruno, M. A., Ducatenzeiler, A., Klein, W. L., & Cuello, A. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.007 · Cited by 151
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides
Benson, M. D., Kluve‐Beckerman, B., Zeldenrust, S. R., Siesky, A. M., Bodenmiller, D. M., Showalter, A. D., & Sloop, K. W. (2006) · Muscle & Nerve · doi:10.1002/mus.20503 · Cited by 150
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report
Kristen, A. V., Lehrke, S., Buss, S. J., Mereles, D., Steen, H., Ehlermann, P., Hardt, S. E., Giannitsis, E., Schreiner, R., Haberkorn, U., et al. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0463-z · Cited by 148
Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils
Johan, K., Westermark, G. T., Engström, U., Gustavsson, Å., Hultman, P. A., & Westermark, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2558 · Cited by 147
Seeded strain‐like transmission of β‐amyloid morphotypes in APP transgenic mice
Heilbronner, G., Eisele, Y. S., Langer, F., Kaeser, S. A., Novotny, R., Nagarathinam, A., Åslund, A., Hammarström, P., Nilsson, K. P. R., & Jucker, M. (2013) · EMBO Reports · doi:10.1038/embor.2013.137 · Cited by 147
Self-citationMeilandt, W. J., Cissé, M., Ho, K., Wu, T. Z., Esposito, L., Scearce-Levie, K. A., Cheng, I. H.-J., Yu, G.-Q., & Mucke, L. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2984-08.2009 · Cited by 145
Discovering transthyretin amyloid fibril inhibitors by limited screening
Baures, P. W., Peterson, S., & Kelly, J. W. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00130-8 · Cited by 141
Self-citationUnfolded protein response‐induced ERdj3 secretion links ER stress to extracellular proteostasis
Genereux, J. C., Qu, S., Zhou, M., Ryno, L. M., Wang, S., Shoulders, M. D., Kaufman, R. J., Lasmézas, C. I., Kelly, J. W., & Wiseman, R. L. (2014) · The EMBO Journal · doi:10.15252/embj.201488896 · Cited by 139
Self-citationStangou, A. J., Banner, N. R., Hendry, B. M., Rela, M., Portmann, B. C., Wendon, J. A., Monaghan, M. J., MacCarthy, P. A., Buxton-Thomas, M. S., Mathias, C. J., et al. (2009) · Blood · doi:10.1182/blood-2009-06-223792 · Cited by 139
Miyata, Y., Li, X., Lee, H.-F., Jinwal, U. K., Srinivasan, S. R., Seguin, S. P., Young, Z. T., Brodsky, J. L., Dickey, C. A., Sun, D., et al. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300210g · Cited by 139
Lindström, V., Fagerqvist, T., Nordström, E. K. L., Eriksson, F., Lord, A., Tucker, S. M., Andersson, J., Johannesson, M., Schell, H., Kahle, P. J., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.009 · Cited by 138
Hurshman, A. R., Powers, E. T., & Kelly, J. W. (2008) · Biochemistry · doi:10.1021/bi800636q · Cited by 138
Self-citationGarai, K., & Frieden, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222478110 · Cited by 138
Analysis of the Inhibition and Remodeling of Islet Amyloid Polypeptide Amyloid Fibers by Flavanols
Cao, P., & Raleigh, D. P. (2012) · Biochemistry · doi:10.1021/bi2015162 · Cited by 135
Maia, L. F., Magalhães, R., Freitas, J., Taipa, R. J. F., Pires, M. M., Osório, H., Dias, D., Pessegueiro, H., Correia, M. A., & Coelho, T. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308107 · Cited by 134
A PECULIAR FORM OF PERIPHERAL NEUROPATHY
Andrade, C. (1951) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1951.tb09673.x · Cited by 130
Chaperone networks in protein disaggregation and prion propagation
Winkler, J., Tyedmers, J., Bukau, B., & Mogk, A. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.05.002 · Cited by 126
Familial amyloidotic polyneuropathy
Benson, M. D., & Roudebush, R. L. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90162-8 · Cited by 125
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma
Purkey, H. E., Dorrell, M. I., & Kelly, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091431798 · Cited by 124
Self-citationFalk, R. H. (2011) · Circulation · doi:10.1161/circulationaha.110.010447 · Cited by 124
Imbalance of Hsp70 family variants fosters tau accumulation
Jinwal, U. K., Akoury, E., Abisambra, J. F., O’Leary, J. C., Thompson, A. D., Blair, L. J., Jin, Y., Bacon, J. A., Nordhues, B. A., Cockman, M. E., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-220889 · Cited by 121
Guo, J., & Lee, V. M. ‐. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.051 · Cited by 120
Learning by Failing: Ideas and Concepts to Tackle γ-Secretases in Alzheimer's Disease and Beyond
De Strooper, B., & Chávez Gutiérrez, L. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124309 · Cited by 119
Hasegawa, K., Ono, K., Yamada, M., & Naiki, H. (2002) · Biochemistry · doi:10.1021/bi020369w · Cited by 117
Hsc70 Protein Interaction with Soluble and Fibrillar α-Synuclein
Pemberton, S., Madiona, K., Pieri, L., Kabani, M., Bousset, L., & Melki, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.261321 · Cited by 114
Immunoglobulin light chain amyloidosis
Merlini, G., Comenzo, R. L., Seldin, D. C., Wechalekar, A. D., & Gertz, M. A. (2013) · Expert Review of Hematology · doi:10.1586/17474086.2014.858594 · Cited by 110
Abisambra, J. F., Jinwal, U. K., Miyata, Y., Rogers, J. T., Blair, L. J., Li, X., Seguin, S. P., Wang, L., Jin, Y. L., Bacon, J. A., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.027 · Cited by 110
Vidal, R., Garzuly, F., Budka, H., Lalowski, M. M., Linke, R., Brittig, F., Frangione, B., & Wısnıewskı, T. (1996) · Europe PMC (PubMed Central) · Cited by 108
Zhang, Y.-Q., & Sarge, K. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0251-9 · Cited by 108
Hamaguchi, T., Eisele, Y. S., Varvel, N. H., Lamb, B. T., Walker, L. C., & Jucker, M. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0912-1 · Cited by 106
Self-citationSchneider, F., Hammarström, P., & Kelly, J. W. (2001) · Protein Science · doi:10.1110/ps.8901 · Cited by 105
Self-citationImmunotherapy for Alzheimer's disease
Wısnıewskı, T., & Goñi, F. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.020 · Cited by 104
Shelkovnikova, T. A., Robinson, H. K., Southcombe, J. A., Ninkina, N. N., & Buchman, V. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu243 · Cited by 102
Gertz, M. A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21934 · Cited by 100
Long-term data from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR)
Wilczek, H., Larsson, M. Å., Ericzon, B. G., et al. (2011) · Amyloid · doi:10.3109/13506129.2011.574354072 · Cited by 97
Multiple Factors Contribute to the Peripheral Induction of Cerebral -Amyloidosis
Eisele, Y. S., Fritschi, S. K., Hamaguchi, T., Obermüller, U., Füger, P., Skodras, A., Schafer, C., Odenthal, J., Heikenwälder, M. F., Staufenbiel, M., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1608-14.2014 · Cited by 95
Self-citationBortezomib in the treatment of AL amyloidosis: targeted therapy?
Sitia, R., Palladini, G. O., & Merlini, G. (2007) · Haematologica · doi:10.3324/haematol.12136 · Cited by 93
Cooley, C. B., Ryno, L. M., Plate, L., Morgan, G. J., Hulleman, J. D., Kelly, J. W., & Wiseman, R. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406050111 · Cited by 87
Self-citationTransthyretin Cardiac Amyloidoses in Older North Americans
Dharmarajan, K., & Maurer, M. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03868.x · Cited by 80
Suhr, O. B., Hietala, S.-O., Riklund, K., Pepys, M. B., Hawkins, P. N., & Rydh, A. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050273 · Cited by 80
Protective Role of Heat Shock Proteins in Parkinson’s Disease
Aridon, P., Geraci, F., Turturici, G., D’Amelio, M., Savettieri, G., & Sconzo, G. (2011) · Neurodegenerative Diseases · doi:10.1159/000321548 · Cited by 78
Singh, R., Kølvraa, S., Bross, P., et al. (2006) · Cell Stress and Chaperones · doi:10.1379/csc-184r.1 · Cited by 73
Aging as a major risk for degenerative diseases of the central nervous system
Amaducci, L. A., & Tesco, G. (1994) · Current Opinion in Neurology · doi:10.1097/00019052-199408000-00001 · Cited by 71
Impact of Liver Transplantation on Cardiac Autonomic Denervation in Familial Amyloid Polyneuropathy
Delahaye, N., Rouzet, F., Sarda‐Mantel, L., Tamas, C., Dinanian, S., Planté‐Bordeneuve, V., Adams, D., Samuel, D., Merlet, P., Syrota, A., et al. (2006) · Medicine · doi:10.1097/01.md.0000232559.22098.c3 · Cited by 68
Arendt, B. K., Ramírez-Alvarado, M., Sikkink, L. A., Keats, J. J., Ahmann, G. J., Dispenzieri, A. A., Fonseca, R., Ketterling, R. P., Knudson, R. A., Mulvihill, E. M., et al. (2008) · Blood · doi:10.1182/blood-2008-03-143040 · Cited by 68
Genetic Stabilization of Transthyretin, Cerebrovascular Disease, and Life Expectancy
Hornstrup, L. S., Frikke‐Schmidt, R., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301273 · Cited by 64
Sahlin, C., Lord, A., Magnusson, K., Englund, H., Almeida, C. G., Greengard, P., Nyberg, F., Gouras, G. K., Lannfelt, L., & Nilsson, L. N. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04443.x · Cited by 63
Small Molecule Inducers of Heat-Shock Response Reduce polyQ-Mediated Huntingtin Aggregation
Herbst, M., & Wanker, E. E. (2007) · Neurodegenerative Diseases · doi:10.1159/000101849 · Cited by 63
De novo generation of infectious prions with bacterially expressed recombinant prion protein
Zhang, Z., Zhang, Y., Wang, F., Wang, X., Xu, Y., Yang, H., Yu, G., Yuan, C., & Ma, J. (2013) · The FASEB Journal · doi:10.1096/fj.13-233965 · Cited by 63
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Sambamurti, K., Greig, N. H., Utsuki, T., Barnwell, E., Sharma, E., Mazell, C., Bhat, N. R., Kindy, M. S., Lahiri, D. K., & Pappolla, M. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07213.x · Cited by 62
The E3 Ubiquitin Ligase CHIP and the Molecular Chaperone Hsc70 Form a Dynamic, Tethered Complex
Smith, M. C. P., Scaglione, K. M., Assimon, V. A., Patury, S., Thompson, A. D., Dickey, C. A., Southworth, D. R., Paulson, H. L., Gestwicki, J. E., & Zuiderweg, E. R. P. (2013) · Biochemistry · doi:10.1021/bi4009209 · Cited by 58
Gavilán, M. P., Pintado, C., Gavilán, E., Jiménez, S., Rios, R. M., Vitórica, J., Castaño, A., & Ruano, D. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00519.x · Cited by 58
Page, L. J., Suk, J. Y., Bazhenova, L. A., Fleming, S. M., Wood, M. R., Jiang, Y., Guo, L. T., Mizisin, A. P., Kisilevsky, R., Shelton, G. D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811753106 · Cited by 58
Self-citationMonis, G. F., Schultz, C., Ren, R., Eberhard, J., Costello, C. E., Connors, L. H., Skinner, M. M., & Trinkaus‐Randall, V. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060183 · Cited by 57
Munar-Qués, M., Salvá-Ladaria, L., Mulet-perera, P., Solé, M., López-Andreu, F., & Saraiva, M. J. (2000) · Amyloid · doi:10.3109/13506120009146440 · Cited by 55
Srinivasan, S., Patke, S., Wang, Y., Ye, Z., Litt, J., Srivastava, S. K., López, M. M., Kurouski, D., Lednev, I. K., Kane, R. S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.394155 · Cited by 54
Delayed‐start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years
Liu‐Seifert, H., Siemers, E., Holdridge, K. C., Andersen, S. W., Lipkovich, I. A., Carlson, C. D., Sethuraman, G., HOOG, S. L., Hayduk, R., Doody, R. S., et al. (2015) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.06.006 · Cited by 53
Physiological IgM Class Catalytic Antibodies Selective for Transthyretin Amyloid
Planque, S. A., Nishiyama, Y., Hara, M., Sonoda, S., Murphy, S. K., Watanabe, K., Mitsuda, Y., Brown, E. L., Massey, R. J., Primmer, S. R., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557231 · Cited by 53
Bersuker, K., Hipp, M. S., Calamini, B., Morimoto, R. I., & Kopito, R. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.481945 · Cited by 51
Hong, M., Alexeyenko, A., Lambert, J., Amouyel, P., & Prince, J. A. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.92 · Cited by 50
Hall, A., & Patel, T. R. (2014) · Progress in medicinal chemistry · doi:10.1016/b978-0-444-63380-4.00003-2 · Cited by 49
Structure, mechanism and inhibition of γ-secretase and presenilin-like proteases
Wolfe, M. S. (2010) · Biological Chemistry · doi:10.1515/bc.2010.086 · Cited by 48
Wang, Q., Guo, J., Jiao, P., Liu, H., & Yao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094796 · Cited by 47
Aggregate-Depleted Brain Fails to Induce Aβ Deposition in a Mouse Model of Alzheimer's Disease
Duran-Aniotz, C. A., Morales, R., Moreno‐González, I., Hu, P. P., Fedynyshyn, J. P., & Soto, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089014 · Cited by 45
Zhou, P., Ma, X., Iyer, L. K., et al. (2014) · Blood · doi:10.1182/blood-2013-10-535187 · Cited by 45
The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy
Shimshek, D. R., Müeller, M., Wießner, C., Schweizer, T., & van der Putten, P. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010014 · Cited by 44
Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment
Benson, M. D., Smith, R. A., Hung, G., Kluve‐Beckerman, B., Showalter, A. D., Sloop, K. W., & Monia, B. P. (2010) · Amyloid · doi:10.3109/13506129.2010.483121 · Cited by 44
From Soluble A β to Progressive A β Aggregation: Could Prion‐Like Templated Misfolding Play a Role?
Eisele, Y. S. (2013) · Brain Pathology · doi:10.1111/bpa.12049 · Cited by 43
Self-citationShoulders, M. D., Ryno, L. M., Cooley, C. B., Kelly, J. W., & Wiseman, R. L. (2013) · Journal of the American Chemical Society · doi:10.1021/ja402756p · Cited by 42
Self-citationEleuteri, S., Giovanni, S. D., Rockenstein, E. M., Mante, M., Adame, A., Trejo, M., Wrasidlo, W., Wu, F., Fraering, P. C., Masliah, E., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.017 · Cited by 41
Preclinical development of siRNA therapeutics for AL amyloidosis
Hovey, B. M., Ward, J. E., Hoo, P. S., O’Hara, C., Connors, L. H., & Seldin, D. C. (2011) · Gene Therapy · doi:10.1038/gt.2011.69 · Cited by 39
Reversing deleterious protein aggregation with re-engineered protein disaggregases
Jackrel, M. E., & Shorter, J. (2014) · Cell Cycle · doi:10.4161/cc.28709 · Cited by 38
Pharmacological Tuning of Heat Shock Protein 70 Modulates Polyglutamine Toxicity and Aggregation
Chafekar, S. M., Wisén, S., Thompson, A. D., Echeverria, A., Walter, G. M., Evans, C. G., Makley, L. N., Gestwicki, J. E., & Duennwald, M. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300166p · Cited by 35
Casaccia‐Bonnefil, P., Kascsak, R., Fersko, R., Callahan, S. M., & Carp, R. I. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.1.7 · Cited by 31
Hopes remain for an Alzheimer's vaccine
Schenk, D. (2004) · Nature · doi:10.1038/431398b · Cited by 30
Kisilevsky, R., Narindrasorasak, S., Tape, C., Tan, R., & Boudreau, L. (1994) · Amyloid · doi:10.3109/13506129409148449 · Cited by 29
Kuroda, T., Tanabe, N., Kobayashi, D., Sato, H., Wada, Y., Murakami, S., Saeki, T., Nakano, M., & Narita, I. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.111453 · Cited by 29
Takeda, N., Kume, S., Tanaka, Y., Morita, Y., Chin‒Kanasaki, M., Araki, H., Isshiki, K., Araki, S., Haneda, M., Koya, D., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.026 · Cited by 28
Modulators of amyloid protein aggregation and toxicity: EGCG and CLR01
Attar, A., Rahimi, F., & Bitan, G. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0137-y · Cited by 24
Metal-dependent amyloid β-degrading catalytic antibody construct
Nishiyama, Y., Taguchi, H., Hara, M., Planque, S. A., Mitsuda, Y., & Paul, S. (2014) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.03.026 · Cited by 24
Cited by
Xue, C., Lin, T. Y., Chang, D., & Guo, Z. (2017) · Royal Society Open Science · doi:10.1098/rsos.160696 · Cited by 807
The activities of amyloids from a structural perspective
Riek, R., & Eisenberg, D. S. (2016) · Nature · doi:10.1038/nature20416 · Cited by 508
Antisense Oligonucleotide Therapies for Neurodegenerative Diseases
Bennett, C. F., Krainer, A. R., & Cleveland, D. W. (2019) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070918-050501 · Cited by 353
Breaking BAG: The Co-Chaperone BAG3 in Health and Disease
Behl, C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.007 · Cited by 261
Pathogenic mechanisms of somatic mutation and genome mosaicism in aging
Vijg, J., & Dong, X. (2020) · Cell · doi:10.1016/j.cell.2020.06.024 · Cited by 240
Metadata
- Authors
- Eisele, Y. S., Monteiro, C., Fearns, C., Encalada, S. E., Wiseman, R. L., Powers, E. T., & Kelly, J. W.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-09-04
- Volume
- 14
- Issue
- 11
- Pages
- 759-780
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1856496738
- Cited by
- 419
- References
- 292
- FWCI
- 5.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.